The odds ratio for exposure to L-dopa in the IPD patients with PN was 12.4 (95% confidence interval, 1.4–109.1). There were no differences between the groups in the use of other PD drugs ...

NLX-101 (F15599) is under development for the treatment of Rett syndrome and depression. The drug candidate is administered by oral route. The drug candidate is a new chemical entity (NCE). The drug ...

Discover the truth in our NeuroQuiet reviews – does this hearing support supplement really deliver on its promises, or is it ...

Mavoglurant is under development for the treatment of cocaine use disorder, alcohol use disorder and for language learning in young children with fragile X syndrome (FXS). The drug candidate is ...

NeuroQuiet is an advanced auditory support supplement that takes hearing experience to the next level. It strategically ...

L-dopa remains the most powerful antiparkinsonian agent, but a minority of treated patients develop disabling motor response complications. Alternatives to L-dopa for initial treatment of ...

Discover the truth about improved hearing with NeuroQuiet reviews—real experiences, benefits, and results revealed in this ...

The cuttlefish can use its beak to help subdue prey and to ... The ink, which contains dopamine and L-DOPA, a precursor to dopamine, may also temporarily paralyze the sense of smell in predators ...

A registered dietitian shares 13 of the healthiest energy drinks available on the market, based on nutritional value and ingredients.

U of A researchers have uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug levodopa.